Finance

Beta
Lists
EMR:NYSE
Emerson Electric Co
$150.21
-0.30%
(-0.45) 1D
$150.21
0.00% (0.00)
After hours
Closed: Jun 22, 4:00:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EMR...
Open
$150.72
High
$152.00
Low
$149.37
Mkt. cap
84.13B
Avg. vol.
2.82M
Volume
2.81M
Dividend
1.48%
Quarterly dividend
$0.56
Ex-dividend date
May 15, 2026
P/E ratio
34.68
52-wk high
$165.15
52-wk low
$122.64
EPS
$4.33
Beta
1.25
Shares outstanding
560.10M
No. of employees
71K
Open
$150.72
High
$152.00
Low
$149.37
Mkt. cap
84.13B
Avg. vol.
2.82M
Volume
2.81M
Dividend
1.48%
Quarterly dividend
$0.56
Ex-dividend date
May 15, 2026
P/E ratio
34.68
52-wk high
$165.15
52-wk low
$122.64
EPS
$4.33
Beta
1.25
Shares outstanding
560.10M
No. of employees
71K
News stories
From sources across the web
Profile
Emerson Electric Co., commonly known as Emerson, is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company manufactures and delivers a range of industrial automation and control systems, climate control solutions, measurement and analytical instrumentation, and provides engineering services for industrial, commercial, and consumer markets. Wikipedia
About Emerson Electric Co
CEOLal Karsanbhai
Employees71K
FoundedSep 24, 1890
HeadquartersSt. Louis, Missouri, United States
Sectorcapital good
Websiteemerson.com
Analyst Ratings
Based on 15 analysts giving stock ratings to EMR in the past 3 months
Buy
Buy
8
Hold
6
Sell
1
12 month forecast
Based on 15 Wall Street analysts offering 12 month price targets for EMR in the last 3 months.
Highest
Current $150.21
$185.00 (+23.16%)
Average
$160.86 (+7.09%)
Lowest
$125.00 (-16.78%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Unknown Analyst
Davidson Capital
Hold
Initiated
$145.00
-3.5%
06/16/2026
Chris Dankert
D.A. Davidson
Hold
Initiated
$145.00
-3.5%
06/16/2026
Unknown Analyst
D.A. Davidson
Hold
Initiated
$145.00
-3.5%
06/15/2026
Andrew Obin
Bank of America Securities
Buy
Maintained
-
-
06/15/2026
Unknown Analyst
Bernstein
Buy
Initiated
$175.00
+16.5%
06/09/2026
Varun Govindaraj
Bernstein
Buy
Initiated
$175.00
+16.5%
06/09/2026
Alexander Virgo
Evercore ISI
Buy
Maintained
$185.00
+23.2%
05/21/2026
Joe O'Dea
Wells Fargo
Hold
Reiterated
$155.00
+3.2%
05/08/2026
Jim Kelleher
Argus Research
Buy
Maintained
$175.00
+16.5%
05/08/2026
Unknown Analyst
Argus Research
Buy
Maintained
$175.00
+16.5%
05/08/2026
Joseph C Giordano
TD Cowen
Hold
Reiterated
$150.00
-0.1%
05/07/2026
Deane Dray
RBC Capital
Buy
Reiterated
$169.00
+12.5%
05/06/2026
Christopher Snyder
Morgan Stanley
Sell
Maintained
$125.00
-16.8%
05/05/2026
Julian Mitchell
Barclays
Hold
Maintained
$144.00
-4.1%
05/06/2026
Kenneth Newman
KeyBanc
Buy
Reiterated
$185.00
+23.2%
05/06/2026
Andrew Kaplowitz
Citi
Buy
Maintained
$174.00
+15.8%
04/13/2026
Stephen Volkmann
Jefferies
Buy
Upgraded
$175.00
+16.5%
03/31/2026
Raj Ray
BMO Capital
Hold
Initiated
$150.00
-0.1%
03/27/2026
Daniel DiCicco
BMO Capital
Hold
Initiated
$150.00
-0.1%
03/27/2026
Tommy Moll
Stephens
Hold
Maintained
$155.00
+3.2%
02/09/2026
Nicole Deblase
Deutsche Bank
Hold
Downgraded
$170.00
+13.2%
02/04/2026
Brett Linzey
Mizuho Securities
Buy
Maintained
$173.00
+15.2%
02/04/2026
Michael Halloran
Robert W. Baird
Hold
Maintained
$168.00
+11.8%
02/04/2026
Last report
May 5, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$1.54 / $1.54
-0.13%miss
Revenue / Est. (USD)
4.56B / 4.59B
-0.69%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.55B
4.86B
4.35B
4.56B
Cost of goods sold
2.16B
2.34B
2.04B
2.14B
Cost of revenue
2.16B
2.34B
2.04B
2.14B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.27B
1.33B
1.24B
1.32B
Operating expense
1.47B
710.00M
1.24B
1.32B
Total operating expenses
3.63B
3.05B
3.28B
3.46B
Operating income
922.00M
1.81B
1.07B
1.11B
Other non operating income
-
-803.00M
-181.00M
-164.00M
EBT including unusual items
734.00M
796.00M
775.00M
793.00M
EBT excluding unusual items
796.00M
895.00M
785.00M
839.00M
Income tax expense
154.00M
160.00M
169.00M
175.00M
Effective tax rate
20.98%
20.10%
21.81%
22.07%
Other operating expenses
205.00M
-620.00M
-
-
Net income
586.00M
636.00M
605.00M
618.00M
Net profit margin
12.87%
13.10%
13.92%
13.55%
Earnings per share
1.52
1.62
1.46
1.54
Interest and investment income
31.00M
30.00M
26.00M
26.00M
Interest expense
-126.00M
-122.00M
-116.00M
-110.00M
Net interest expenses
-95.00M
-92.00M
-90.00M
-84.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.27B
2.16B
1.41B
1.45B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer